LB Pharmaceuticals


Public lists: Pharma Startups (4733)

LB Pharmaceuticals is a drug development company focused on development treatments for CNS disorders. LB currently has two drugs in its' pipeline. LB-101 is existing anti-psychotic currently marketed outside the United States and for which the company is working on developing a pathway for US approval. LB-102 is a targeted compound for the treatment of schizophrenia owned and development internally by LB. LB-102 is currently in pre-clinical development.

LB Pharmaceuticals is a drug development company focused on development treatments for CNS disorders. LB currently has two drugs in its' pipeline. LB-101 is existing anti-psychotic currently marketed outside the United States and for which the compan...Show all

Company (Alive / Active)

Phone: 917-450-6581

Fax:

575 Madison Avenue
10th Floor
New York, 10022
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
LB Pharmaceuticals $2.2M May 29, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related LB Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)